Atricure announces that the first patient has been treated with the revolutionary atriclip® flex-mini™ device

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the first patient was treated with the atriclip® flex-mini™ device, which recently received 510(k) clearance. the atriclip flex-mini sets a new standard as the smallest profile surgical laa device on the market and builds upon the proven technology of.
ATRC Ratings Summary
ATRC Quant Ranking